Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (271-280 of 406) with videos related to

Pageof 41
Sort By:
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Phase I trial of interleukin-2 plus gamma-interferonK A Margolin, J H Doroshow, S A Akman, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 12, 2025
A real-world population-based study on the association between cataracts and antipsychoticsMoiz Lakhani, Angela T H Kwan, Emaan Chaudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanomaK A Margolin, J H Doroshow, S A Akman, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II studyBrian I Rini, Susan Halabi, Robert Barrier, et al.
Blood|December 8, 2009
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cellsKatia Basso, Masumichi Saito, Pavel Sumazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804)Keith T Flaherty, Judith B Manola, Michael Pins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinomaM B Atkins, J Sparano, R I Fisher, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinomaG R Weiss, K A Margolin, M Sznol, et al.
Pageof 41

Showing results (271-280 of 406) with videos related to

Sort By:
Pageof 41
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Phase I trial of interleukin-2 plus gamma-interferonK A Margolin, J H Doroshow, S A Akman, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 12, 2025
A real-world population-based study on the association between cataracts and antipsychoticsMoiz Lakhani, Angela T H Kwan, Emaan Chaudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanomaK A Margolin, J H Doroshow, S A Akman, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II studyBrian I Rini, Susan Halabi, Robert Barrier, et al.
Blood|December 8, 2009
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cellsKatia Basso, Masumichi Saito, Pavel Sumazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804)Keith T Flaherty, Judith B Manola, Michael Pins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinomaM B Atkins, J Sparano, R I Fisher, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinomaG R Weiss, K A Margolin, M Sznol, et al.
Pageof 41